ストックスクリーナーアプリを入手
2.03
1.93%
-0.04
前日終値:
$2.07
開ける：
$2.07
24時間の取引高:
95,877
Relative Volume:
0.04
時価総額：
$3.02M
収益：
-
当期純損益:
$-6.64M
株価収益率:
-0.0113
EPS:
-179.3009
ネットキャッシュフロー:
$-5.60M
1週間 パフォーマンス:
-13.98%
1か月 パフォーマンス:
-36.56%
6か月 パフォーマンス:
-91.36%
1年 パフォーマンス:
-99.48%
1日の値動き範囲:
$2.03
$2.15
1週間の範囲:
$2.00
$2.35
52週間の値動き範囲:
$2.00
$524.00
Clearmind Medicine Inc Stock (CMND) Company Profile
Compare CMND vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
2.03 | 3.02M | 0 | -6.64M | -5.60M | -179.30 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Clearmind Medicine Inc (CMND) 最新ニュース
Clearmind Medicine Submits Formal Response To HHS RFI Highlighting MEAI-Based Candidate CMND-100 For Alcohol Use Disorder And Binge Behaviors - marketscreener.com
Clearmind submits addiction treatment proposal to U.S. HHS - Investing.com India
Clearmind submits MEAI addiction treatment prop... - Pluang
Clearmind Medicine Submits Response to HHS RFI Highlighting MEAI-Based CMND-100 for Alcohol Use Disorder - Quiver Quantitative
Clearmind Medicine (CMND) reports successful intranasal MEAI feasibility study - Stock Titan
Clearmind Medicine : Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration for MEAI - marketscreener.com
CMND Stock Slides As Traders Gauge Cash Runway And Volatility - StocksToTrade
Clearmind Medicine Reports Successful Formulation Feasibility for Intranasal MEAI Development Program for Alcohol Use Disorder - Quiver Quantitative
Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI - Yahoo Finance UK
Clearmind Medicine Company Profile & Introduction - Moomoo
symbol__ Stock Quote Price and Forecast - CNN
Clearmind Medicine receives U.S. patent for binge behavior treatment - Investing.com UK
Clearmind Medicine receives U.S. patent for binge behavior treatment By Investing.com - Investing.com Australia
Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength - The Manila Times
Clearmind Medicine(CMND) Stock Options Chain | Quotes & News - Moomoo
Price to earnings forward of Clearmind Medicine Inc. – MUN:CWY0 - TradingView
Price to earnings forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView
Enterprise value to revenue forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView
Price to sales forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView
Price to book forward of Clearmind Medicine Inc. – NASDAQ:CMND - TradingView
Clearmind Medicine Reaches Major Milestone, Completing Part a Treatment in FDA-Regulated Phase I/II Trial - marketscreener.com
Clearmind Medicine Inc (CMND) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Clearmind completes treatment phase of alcohol disorder trial - Investing.com UK
Clearmind Medicine (CMND) Completes Phase I/II Trial for Alcohol Use Disorder - GuruFocus
Clearmind completes treatment phase of alcohol disorder trial By Investing.com - Investing.com South Africa
Form 6K Clearmind Medicine Inc For: 22 June By Investing.com - Investing.com Nigeria
Clearmind Medicine Completes Treatment for All Participants in Part A of Phase I/II Trial of CMND-100 for Alcohol Use Disorder - Quiver Quantitative
Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial - The Manila Times
Clearmind Medicine (Nasdaq: CMND) hits CMND-100 Phase I/II milestone - Stock Titan
Insider Selling: Financial Hrt Sells Shares of Clearmind Medicine Inc (CMND) - GuruFocus
HRT Financial LP trims Clearmind Medicine (CMND) stake with 22,139-share sale - Stock Titan
Clearmind Medicine Granted U.S. Patent for Binge Behavior Regulators - The Manila Times
Clearmind Medicine (NASDAQ: CMND) secures U.S. patent for MEAI binge behavior regulators - Stock Titan
Clearmind Medicine Inc Share PriceCMND, RNS News, Articles, Quotes, & Charts (NASDAQ:CMND) - Proactive financial news
Insider Sell: Financial Hrt Reduces Stake in Clearmind Medicine Inc (CMND) - GuruFocus
Clearmind Medicine Inc (CMND) Institutional Confidence - TradingKey
Clearmind Medicine Inc (CMND) Valuation: PE, PB & Fair Value Analysis - TradingKey
Clearmind Medicine (CMND) holder HRT Financial LP sells 3,183 shares - Stock Titan
Clearmind Medicine Inc (CMND) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Clearmind Medicine Inc (CMND) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Clearmind Medicine Inc (CMND) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Clearmind Medicine Inc (CMND) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Clearmind Medicine Inc (CMND) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Clearmind Medicine Inc (CMND) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Clearmind completes dosing for phase I/II alcohol disorder trial By Investing.com - Investing.com South Africa
Clearmind Medicine finishes dosing 24 trial participants - grafa.com
Clearmind completes dosing for phase I/II alcohol disorder trial - Investing.com UK
HRT Financial LP trims Clearmind Medicine (CMND) stake with 2,102-share sale - Stock Titan
Clearmind Medicine Inc (CMND) 財務データ
収益
当期純利益
現金流量
EPS
2.64%
大文字化:
|
ボリューム (24 時間):